Time to exceed pre‐randomization monthly seizure count for perampanel in participants with primary generalized tonic–clonic seizures: A potential clinical end point-Reference-Cited by-同舟云学术

Time to exceed pre‐randomization monthly seizure count for perampanel in participants with primary generalized tonic–clonic seizures: A potential clinical end point

Published:2022-09-30 Issue:11 Volume:63 Page:2994-3004
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Kerr Wesley T.¹^ORCID,Brandt Christian²^ORCID,Ngo Leock Y.³,Patten Anna⁴,Cheng Jocelyn Y.³,Kramer Lynn³,French Jacqueline A.⁵^ORCID

Affiliation:

1. Department of Neurology University of Michigan Ann Arbor Michigan USA

2. Bethel Epilepsy Center University Hospital for Epileptology Bielefeld Germany

3. Department of Neurology Eisai Inc. Nutley New Jersey USA

4. Department of Biostatistics Eisai Hatfield UK

5. Comprehensive Epilepsy Center New York University New York City New York USA

Funder

American Epilepsy Society

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/epi.17411

Reference25 articles.

1. Risk of sudden unexpected death in epilepsy in patients given adjunctive antiepileptic treatment for refractory seizures: a meta-analysis of placebo-controlled randomised trials

2. SUDEP in the North American SUDEP Registry

3. Risk Assessment for Sudden Death in Epilepsy: The SUDEP-7 Inventory

4. Can machine learning improve randomized clinical trial analysis?

5. Natural variability in seizure frequency: Implications for trials and placebo

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Demonstration of Group-Level and Individual-Level Efficacy Using Time-to-Event Designs for Clinical Trials of Antiseizure Medications;Neurology;2024-08-27

2. Time to prerandomization seizure count design sufficiently assessed the safety and tolerability of perampanel for the treatment of primary generalized tonic–clonic seizures;Epilepsia;2024-06-12

3. Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference;Epilepsia;2024-01-05

4. Machine Learning and Artificial Intelligence Applications to Epilepsy: a Review for the Practicing Epileptologist;Current Neurology and Neuroscience Reports;2023-12

5. Sustainability of seizure reduction and seizure control with adjunctive cenobamate: Post hoc analysis of a phase 3, open‐label study;Epilepsia;2023-08-07